Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
1 Aug 2025
New Drug Pairing Offers Hope for Advanced Skin Lymphoma
A new combination treatment may offer a promising option for patients with relapsed or refractory cutaneous T-cell lymphoma….
1 Aug 2025
Home-Based Brain Stimulation Reduces Pain and Disability in Fibromyalgia
A randomised trial finds that home-based brain stimulation plus exercise and education reduces pain-related disability in fibromyalgia patients, even among placebo responders.
1 Aug 2025
Doxycycline After Sex Significantly Reduces Bacterial STI Risk
Taking doxycycline after condomless sex significantly reduced bacterial STIs in men who have sex with men and transgender women.
FDA and NICE: Two leaders step down in same week
Two major health agencies are facing leadership reshuffles, with the resignations of the FDA’s Vinay Prasad and NICE’s Dr Sam Roberts.
1 Aug 2025
HPV Vaccine Significantly Reduces Actinic Keratosis Lesions
Results from the 12-month double-blind, placebo-controlled trial revealed that the vaccinated group consistently experienced greater reductions in AK lesions than the control group.
31 Jul 2025
CANYON: The Largest Interventional Trial in Becker
Sevasemten is an investigational agent that is currently not approved for use by any regulatory authority in any territory…
31 Jul 2025
Obesity Severity and Tirzepatide’s Impact on Heart Failure Outcomes: New Insights
Tirzepatide improves outcomes in heart failure with obesity, with greatest physical benefits seen in those with higher BMI.
31 Jul 2025
Pelvic Floor and Relaxation Exercises Ease Menstrual Pain
A growing body of research supports non-pharmacological treatments, particularly exercise, as effective in alleviating primary dysmenorrhea symptoms.
3
Mins
31 Jul 2025
A New Era in Asthma and COPD: Interview with Sir Peter Barnes
For more than 40 years, I have been involved in asthma and COPD research. The clinical management of these diseases has changed…
10
Mins
31 Jul 2025
Rethinking Mild Asthma in Primary Care
BATURA trial results showed that as-needed use of an ICS-SABA combination may help control symptoms and mitigate exacerbation risk…
←
1
2
3
…
8
9
10
11
12
13
14
…
1,255
1,256
1,257
→
We’ve noticed you’re accessing
from
North/South America.
View
View